Literature DB >> 20036814

TGF-beta signaling, tumor microenvironment and tumor progression: the butterfly effect.

Amit Joshi1, Deliang Cao.   

Abstract

Transforming growth factor-beta (TGF-beta) signals through receptor serine/threonine kinases and intracellular Smad effectors, regulating numerous epithelial cell processes. TGF-beta plays a crucial role in the cancer initiation and progression through tumor cell autonomous signaling and interactions with tumor microenvironment, but is featured with a butterfly effect upon the stages of tumorigenesis. TGF-beta signaling acts as a suppressor of epithelial cell tumorigenesis at early stages, but promotes tumor progression by enhancing migration, invasion, and survival of the tumor cells during the later stages. TGF-beta signaling also cross-talks with other cell survival signaling pathways. Tumor microenvironment contains many distinct cell types, which substantially influences the tumor cell growth and survival, and the invasion and metastasis. TGF-beta in the microenvironment, produced by cancer and/or stromal cells, is high and negatively correlates with disease progression and patient prognosis. Therefore, TGF-beta may affect tumor progression by multiple mechanisms in addition to its direct action on tumor cells, and the diversities of TGF-beta signaling in tumors imply a need for caution to TGF-beta-targeted strategies of tumor prevention and/or therapeutics.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20036814     DOI: 10.2741/3614

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN: 2768-6698


  38 in total

Review 1.  The role of cytokines in breast cancer development and progression.

Authors:  Marcela Esquivel-Velázquez; Pedro Ostoa-Saloma; Margarita Isabel Palacios-Arreola; Karen E Nava-Castro; Julieta Ivonne Castro; Jorge Morales-Montor
Journal:  J Interferon Cytokine Res       Date:  2014-07-28       Impact factor: 2.607

2.  Relationships between SMAD3 expression and preoperative fluoropyrimidine-based chemoradiotherapy response in locally advanced rectal cancer patients.

Authors:  Ming-Yii Huang; Chih-Hung Lin; Chun-Ming Huang; Hsiang-Lin Tsai; Ching-Wen Huang; Yung-Sung Yeh; Chee-Yin Chai; Jaw-Yuan Wang
Journal:  World J Surg       Date:  2015-05       Impact factor: 3.352

3.  The role of transforming growth factor-beta in suppression of hepatic metastasis from colon cancer.

Authors:  Chandrakanth Are; Neka Simms; Ashwani Rajput; Ashwani Rajupt; Michael Brattain
Journal:  HPB (Oxford)       Date:  2010-09       Impact factor: 3.647

4.  Suppression of malignancy by Smad3 in mouse embryonic stem cell formed teratoma.

Authors:  Peng Li; Ying Chen; Xiaoming Meng; Meng Xiaoming; Ka Yin Kwok; Xiaoru Huang; Kwong Wai Choy; Chi Chiu Wang; Huiyao Lan; Ping Yuan
Journal:  Stem Cell Rev Rep       Date:  2013-10       Impact factor: 5.739

5.  PKM2 and ACVR 1C are prognostic markers for poor prognosis of gallbladder cancer.

Authors:  J Li; Z Yang; Q Zou; Y Yuan; J Li; L Liang; G Zeng; S Chen
Journal:  Clin Transl Oncol       Date:  2013-06-21       Impact factor: 3.405

6.  Reactive oxygen species-mediated PKC and integrin signaling promotes tumor progression of human hepatoma HepG2.

Authors:  Chi-Tan Hu; Jia-Ru Wu; Chuan-Chu Cheng; Sindy Wang; Hsiao-Ting Wang; Ming-Che Lee; Ling-Jung Wang; Siou-Mei Pan; Tsu-Yao Chang; Wen-Sheng Wu
Journal:  Clin Exp Metastasis       Date:  2011-08-14       Impact factor: 5.150

7.  Expression and clinical significance of the transforming growth factor-β signalling pathway in endometrial cancer.

Authors:  Joshua Kesterson; Dan Wang; Paulette Mhawech-Fauceglia; Stacey Akers; Nefertiti Chianti DuPont; Kimberly Clark; Shashikant Lele; Song Liu
Journal:  Histopathology       Date:  2011-07       Impact factor: 5.087

8.  In situ hybridization analysis of the expression of miR-106b in colonic cancer.

Authors:  Ying-Xin Wang; Feng Lang; Yan-Xia Liu; Chang-Qing Yang; Heng-Jun Gao
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

9.  The impact of TGF-β1 on the mRNA expression of TβR I, TβR II, Smad4 and the invasiveness of the JEG-3 placental choriocarcinoma cell line.

Authors:  Yuhong Li; Qian Xu; Zhuo Zhang; Shaochen Liu; Changhua Shi; Yusi Tan
Journal:  Oncol Lett       Date:  2012-09-11       Impact factor: 2.967

10.  Characterization of breast cancer interstitial fluids by TmT labeling, LTQ-Orbitrap Velos mass spectrometry, and pathway analysis.

Authors:  Cinzia Raso; Carlo Cosentino; Marco Gaspari; Natalia Malara; Xuemei Han; Daniel McClatchy; Sung Kyu Park; Maria Renne; Nuria Vadalà; Ubaldo Prati; Giovanni Cuda; Vincenzo Mollace; Francesco Amato; John R Yates
Journal:  J Proteome Res       Date:  2012-05-16       Impact factor: 4.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.